Katrin Fuchs, R. Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan
文献索引:10.1016/j.jconrel.2017.07.016
全文:HTML全文
Embolic microspheres or beads used in transarterial chemoembolization are an established treatment method for hepatocellular carcinoma patients. The occlusion of the tumor-feeding vessels by intra-arterial injection of the beads results in tumor necrosis and shrinkage. In this short review, we describe the utility of using these beads as devices for local drug delivery. We review the latest advances in the development of non-biodegradable and biodegradable drug-eluting beads for transarterial chemoembolization. Their capability to load different drugs, such as chemotherapeutics and anti-angiogenic compounds with different physicochemical properties, like charge and hydrophilicity/hydrophobicity, are discussed. We specifically address controlled and sustained drug release from the microspheres, and the resulting in vivo pharmacokinetics in the plasma vs. drug distribution in the targeted tissue.
Gastroresistant oral peptide for fluorescence imaging of col...
2017-07-19 [10.1016/j.jconrel.2017.07.024] |
Chains of magnetosomes with controlled endotoxin release and...
2017-07-13 [10.1016/j.jconrel.2017.07.020] |
Diphtheria toxoid and N-trimethyl chitosan layer-by-layer co...
2017-07-11 [10.1016/j.jconrel.2017.07.017] |
Amelioration of atherosclerotic inflammation and plaques via...
2017-07-11 [10.1016/j.jconrel.2017.07.019] |
Cationic microbubbles and antibiotic-free miniplasmid for su...
2017-07-11 [10.1016/j.jconrel.2017.07.015] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved